Literature DB >> 12228909

Transitional liver cell tumors (TLCT) in older children and adolescents: a novel group of aggressive hepatic tumors expressing beta-catenin.

Andrzej Prokurat1, Przemysław Kluge, Andrzej Kościesza, Danuta Perek, Andreas Kappeler, Arthur Zimmermann.   

Abstract

BACKGROUND: We encountered on seven malignant hepatocellular tumors developing in older children and adolescents.
RESULTS: These tumors exhibit an unusual phenotype with respect to clinical presentation, histopathology, immunohistochemistry, and treatment response. As a working hypothesis, we suggest that these apparently novel, unusual, and aggressive tumors occurring in older children and adolescents may form a transition in the putative developmental pathway of hepatocarcinogenesis.
CONCLUSION: We therefore propose the term, transitional liver cell tumors (TLCT), to denote these lesions. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12228909     DOI: 10.1002/mpo.10177

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  22 in total

Review 1.  2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations.

Authors:  Ashish Kumar; Subrat K Acharya; Shivaram P Singh; Anil Arora; Radha K Dhiman; Rakesh Aggarwal; Anil C Anand; Prashant Bhangui; Yogesh K Chawla; Siddhartha Datta Gupta; Vinod K Dixit; Ajay Duseja; Naveen Kalra; Premashish Kar; Suyash S Kulkarni; Rakesh Kumar; Manoj Kumar; Ram Madhavan; V G Mohan Prasad; Amar Mukund; Aabha Nagral; Dipanjan Panda; Shashi B Paul; Padaki N Rao; Mohamed Rela; Manoj K Sahu; Vivek A Saraswat; Samir R Shah; Praveen Sharma; Sunil Taneja; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2019-09-23

2.  Characterization of pediatric liver lesions with gadoxetate disodium.

Authors:  Arthur B Meyers; Alexander J Towbin; Suraj Serai; James I Geller; Daniel J Podberesky
Journal:  Pediatr Radiol       Date:  2011-06-24

Review 3.  Hepatoblastoma imaging with gadoxetate disodium-enhanced MRI--typical, atypical, pre- and post-treatment evaluation.

Authors:  Arthur B Meyers; Alexander J Towbin; James I Geller; Daniel J Podberesky
Journal:  Pediatr Radiol       Date:  2012-03-15

Review 4.  Hepatoblastoma: an oncological review.

Authors:  Derek J Roebuck; Giorgio Perilongo
Journal:  Pediatr Radiol       Date:  2006-01-11

Review 5.  The SPLIT research agenda 2013.

Authors:  Estella M Alonso; Vicky L Ng; Ravinder Anand; Christopher D Anderson; Udeme D Ekong; Emily M Fredericks; Katryn N Furuya; Nitika A Gupta; Stacee M Lerret; Shikha Sundaram; Greg Tiao
Journal:  Pediatr Transplant       Date:  2013-05-30

6.  Delta-like protein (DLK) is a novel immunohistochemical marker for human hepatoblastomas.

Authors:  Katalin Dezso; Judit Halász; Hanne Cathrine Bisgaard; Sándor Paku; Eszter Turányi; Zsuzsa Schaff; Peter Nagy
Journal:  Virchows Arch       Date:  2008-01-31       Impact factor: 4.064

Review 7.  International pediatric liver cancer pathological classification: current trend.

Authors:  Yukichi Tanaka; Takeshi Inoue; Hiroshi Horie
Journal:  Int J Clin Oncol       Date:  2013-10-18       Impact factor: 3.402

Review 8.  Hepatocellular carcinoma in children: hepatic resection and liver transplantation.

Authors:  Roberta Angelico; Chiara Grimaldi; Maria Cristina Saffioti; Aurora Castellano; Marco Spada
Journal:  Transl Gastroenterol Hepatol       Date:  2018-09-10

Review 9.  Hepatocellular Malignant Neoplasm, Not Otherwise Specified: A New Name in Liver Tumors: A Brief Narrative Review of Published Cases.

Authors:  Bita Geramizadeh; Razieh Foroughi; Alireza Shojazadeh
Journal:  Gastrointest Tumors       Date:  2021-03-11

10.  Li-Fraumeni syndrome with simultaneous osteosarcoma and liver cancer: increased expression of a CD44 variant isoform after chemotherapy.

Authors:  Go J Yoshida; Yasushi Fuchimoto; Tomoo Osumi; Hiroyuki Shimada; Seiichi Hosaka; Hideo Morioka; Makio Mukai; Yohei Masugi; Michiie Sakamoto; Tatsuo Kuroda
Journal:  BMC Cancer       Date:  2012-10-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.